We are live on ! Find out more
AC

Amici Capital Portfolio holdings

AUM $257M Turnover 61.32%
1-Year Est. Return 4.88%
This Fund
S&P 500
This Quarter Est. Return
+1.98%
1 Year Est. Return
+4.88%
3 Year Est. Return
+28.64%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$257M
AUM Growth
-$126M
Cap. Flow
-$109M
Cap. Flow %
-42.46%
Top 10 Hldgs %
54.36%
Holding
106
New
17
Increased
10
Reduced
24
Closed
48
Avg Time Held Equity + Options
1.6 years
Top 10 Avg Time Held Equity + Options
0.8 years
Top 20 Avg Time Held Equity + Options
0.8 years
Avg Time Held Equity only
2.2 years
Top 10 Avg Time Held Equity only
0.9 years
Top 20 Avg Time Held Equity only
1.1 years

Sector Composition

Rank Sector Weight
1 Miscellaneous 37.47%
2 Healthcare 23.9%
3 Financials 12.96%
4 Communication Services 9.84%
5 Materials 7.48%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
LAD icon
76
Lithia Motors
LAD
$6.48B
– –
-29,000
Closed -$2.77M –
MAR icon
77
CALL
Marriott International
MAR
$104B
– –
-300
Closed -$2.02M –
MAR icon
78
PUT
Marriott International
MAR
$104B
– –
-600
Closed -$4.04M –
OPK icon
79
Opko Health
OPK
$1.24B
– –
-81,000
Closed -$858K –
PBH icon
80
PUT
Prestige Consumer Healthcare
PBH
$2.32B
– –
-300
Closed -$1.45M –
RGLS icon
81
DELISTED
Regulus Therapeutics
RGLS
– –
-688
Closed -$272K –
RIG icon
82
Transocean
RIG
$7.75B
– –
-48,775
Closed -$520K –
SABR icon
83
Sabre
SABR
$654M
– –
-57,000
Closed -$1.61M –
SCI icon
84
Service Corp International
SCI
$10.4B
– –
-135,920
Closed -$3.61M –
SLV icon
85
iShares Silver Trust
SLV
$24B
– –
-95,000
Closed -$1.54M –
SNY icon
86
Sanofi
SNY
$106B
– –
-40,000
Closed -$1.53M –
SSKN icon
87
DELISTED
Strata Skin Sciences
SSKN
– –
-80
Closed -$2K –
TBPH icon
88
DELISTED
Theravance Biopharma
TBPH
– –
-5,705
Closed -$207K –
TEVA icon
89
Teva Pharmaceutical Industries Limited
TEVA
$49.1B
– –
-118,500
Closed -$5.45M –
TLT icon
90
PUT
iShares 20+ Year Treasury Bond ETF
TLT
$48.2B
– –
-1,000
Closed -$13.8M –
TPST icon
91
Tempest Therapeutics
TPST
$9.9M
– –
-3
Closed -$72K –
VLRS icon
92
Controladora Vuela Compania de Aviacion
VLRS
$737M
– –
-40,000
Closed -$696K –
VNDA icon
93
Vanda Pharmaceuticals
VNDA
$229M
– –
-50,000
Closed -$832K –
WPM icon
94
Wheaton Precious Metals
WPM
$52.9B
– –
-93,900
Closed -$2.54M –
CALA
95
DELISTED
Calithera Biosciences, Inc
CALA
– –
-318
Closed -$21K –
FLXN icon
96
DELISTED
Flexion Therapeutics, Inc.
FLXN
– –
-20,000
Closed -$391K –
FIT
97
DELISTED
Fitbit, Inc. Class A common stock
FIT
– –
-31,000
Closed -$460K –
HOS icon
98
DELISTED
Hornbeck Offshore Services, Inc.
HOS
– –
-9,060
Closed -$50K –
BID
99
DELISTED
Sotheby's
BID
– –
-28,800
Closed -$1.1M –
BRS
100
DELISTED
Bristow Group, Inc.
BRS
– –
-78,135
Closed -$1.1M –

Similar funds

Amici Capital's Q4 2016 Portfolio in Review

As of Q4 2016, Amici Capital held 106 positions worth $257M, down 33% from $383M the previous quarter. Its ten largest holdings account for 54% of the portfolio.

Amici Capital withdrew a net $109M in Q4 2016, closing 48 positions and reducing 24 holdings. Its most notable exit was Teva Pharmaceutical Industries Limited, an estimated $5.45M position sold in full.

By sector, the portfolio is most concentrated in Miscellaneous at 37% of assets, up from 32% a quarter earlier, followed by Healthcare and Financials.

Against the trend, Amici Capital opened a new position in First Connecticut Bancorp, Inc worth $32K.

  • Amici Capital's largest Q4 2016 buy was First Connecticut Bancorp, Inc: 250,000 shares worth $32K.
  • Amici Capital added most to Hecla Mining in Q4 2016, an estimated $2.74M increase.
  • Amici Capital's biggest Q4 2016 reduction was BioMarin Pharmaceuticals, cutting an estimated $7.33M.
  • Amici Capital fully exited Teva Pharmaceutical Industries Limited in Q4 2016, selling an estimated $5.45M.
  • Amici Capital's ten largest holdings make up 54% of its $257M portfolio in Q4 2016.
  • Amici Capital opened 17 new positions and closed 48 in Q4 2016.
  • Amici Capital's portfolio value fell 33% quarter-over-quarter to $257M.

Based on Amici Capital's 13F filing for Q4 2016, filed 14 Feb 2017.